Doctor profile · Federal record
Dr. SOUMYA NADELLA, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Internal Medicine Physician · CHESTERFIELD, MO
- NPI 1316350028
- Accepts Medicare
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
224 S WOODS MILL RD STE 480S
CHESTERFIELD, MO 630173609
(366) 857-7446
fax (314) 590-5957 - Mailing address
-
2186 ENGLEWOOD TER
CHESTERFIELD, MO 630177281
Credentials & registration
- NPI registered
- June 2014 — 12 yrs on file
- Profile last updated
- March 6, 2024
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Missouri #2019033228 · Missouri #2014016507
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316350028. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
702
Distinct HCPCS
6
Medicare allowed
$77,162
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 403 | 197 | $126 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 110 | 46 | $34 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 67 | 67 | $164 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 63 | 30 | $78 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 39 | 38 | $129 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 20 | 19 | $89 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 136. This provider delivers 5.2× the peer median.Open Payments
Industry payments received
All-time total
$1,918
Transactions
73
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, Inc. | 3 | $295.09 | |
| Novo Nordisk Inc | 12 | $221.69 | |
| Amgen Inc. | 6 | $198.85 | |
| Abbott Laboratories | 11 | $133.03 | |
| Dexcom, Inc. | 3 | $120.07 | |
| Lilly USA, LLC | 6 | $112.59 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $111.61 | |
| Mannkind Corporation | 5 | $97.62 | |
| RECORDATI_RARE_DISEASES_INC. | 4 | $87.75 | |
| Tandem Diabetes Care, Inc. | 3 | $64.78 | |
| SANOFI-AVENTIS U.S. LLC | 3 | $63.13 | |
| BETA BIONICS, INC. | 3 | $54.85 | |
| ABBVIE INC. | 3 | $54.52 | |
| Novartis Pharmaceuticals Corporation | 3 | $50.92 | |
| Xeris Pharmaceuticals, Inc. | 2 | $43.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,774
Patients
514
Total drug cost
$1,246,836
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trulicity (Dulaglutide) | Brand | 256 | 48 | $410,459 |
| Jardiance (Empagliflozin) | Brand | 208 | 53 | $246,303 |
| Levothyroxine Sodium | Generic | 205 | 63 | $2,913 |
| Atorvastatin Calcium | Generic | 153 | 46 | $1,682 |
| Ozempic (Semaglutide) | Brand | 151 | 41 | $235,274 |
| Metformin Hcl | Generic | 120 | 37 | $1,614 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 109 | 29 | $87,013 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 100 | 38 | $74,675 |
| Rosuvastatin Calcium | Generic | 94 | 31 | $1,569 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 71 | 24 | $87,747 |